2025-05725Notice

NIAID Hides Away to Pick HIV Research Fund Winners

Published Date: 4/3/2025

Notice

Summary

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on May 2, 2025, to review grant applications focused on ending the HIV epidemic. This meeting affects researchers applying for funding and keeps sensitive info private. No public access, but it’s a key step in deciding who gets money to fight HIV.

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Closed Grant Review for HIV Research

Researchers who applied for NIAID R24 grants to support collaborative implementation science to end the HIV epidemic will have their applications reviewed on May 2, 2025, from 1:00 p.m. to 5:00 p.m. at NIAID (video-assisted). This meeting is the formal review and evaluation step used to decide which applicants may receive funding.

Meeting Closed to Protect Confidential Information

The May 2, 2025 meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information in grant applications. Applicants should expect that grant application details and discussions will not be publicly accessible.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Effective Date
4/3/2025
5/2/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
National Institutes of Health
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in